Healius Limited (ASX:HLS)

$4.37

right-arrow Created with Sketch. -0.11 (-2.46%)
MCAP $2.791B
Last trade 16.10pm 27/01/2022 20mins delayed

Latest Announcements

17/12/2021HLSHealius Limited
17/12/2021HLSHealius Limited
17/12/2021 Price SensitivePSHLSHealius Limited
01/12/2021HLSHealius Limited
01/12/2021HLSHealius Limited
30/11/2021HLSHealius Limited
29/11/2021HLSHealius Limited
26/11/2021HLSHealius Limited

Company Overview

Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The Company also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.

HLS in the news

Healius (HLS) is set to acquire the entire issued capital of one…
Healius (HLS) has signed a binding agreement with BGH Capital to sell…
Healius (HLS) has collaborated with mining magnate Andrew Forrest and his Minderoo…

Search Previous Announcements